Shigella iron-binding proteins: An insight into molecular physiology, pathogenesis, and potential target vaccine development

Vaccine. 2022 Jun 26;40(30):3991-3998. doi: 10.1016/j.vaccine.2022.05.061. Epub 2022 May 31.

Abstract

Shigella is a well-known etiological agent responsible for intestinal infection among children, the elderly, and immunocompromised people ranging from mild to severe cases. Shigellosis remains endemic in Malaysia and yet there is no commercial vaccine available to eradicate the disease. Iron is an essential element for the survival of Shigella within the host. Hence, it is required for regulating metabolic mechanisms and virulence determinants. Alteration of iron status in the extracellular environment directly triggers the signal in enteropathogenic bacterial, providing information that they are in a hostile environment. To survive in an iron-limited environment, molecular regulation of iron-binding proteins plays a vital role in facilitating the transportation and utilization of sufficient iron sources. Given the importance of iron molecules for bacterial survival and pathogenicity, this review summarizes the physiological role of iron-binding proteins in bacterial survival and their potential use in vaccine and therapeutic developments.

Keywords: Bacterial pathogenesis; Iron-binding protein; Multiple iron-uptake systems; Shigella species; Siderophores; Vaccine development.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Bacterial Proteins / metabolism
  • Child
  • Dysentery, Bacillary*
  • Humans
  • Iron / metabolism
  • Iron-Binding Proteins / metabolism
  • Shigella*
  • Vaccine Development

Substances

  • Bacterial Proteins
  • Iron-Binding Proteins
  • Iron